Huiqin Yang

8PUBLICATIONS
11CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersChemotherapyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 22, 2026
Targeting IRF1-TRIM21 axis enhances anti-tumor immunity by promoting ubiquitin-mediated degradation of FGL1 in non-small cell lung cancer.

|Jan 13, 2026
Correction: Tumor-derived exosomal tsRNA 3'tiRNA-AlaCGC in promoting fibroblast senescence and Galectin-9 secretion to induce immune tolerance in lung adenocarcinoma.

Guangyin Zhao, Yuchen Zhang, Hongyu Zhang

|Aug 25, 2025
Tumor-derived exosomal tsRNA 3'tiRNA-AlaCGC in promoting fibroblast senescence and Galectin-9 secretion to induce immune tolerance in lung adenocarcinoma.

Guangyin Zhao, Yuchen Zhang, Hongyu Zhang

|Oct 01, 2024
Gram-Negative Microflora Dysbiosis Facilitates Tumor Progression and Immune Evasion by Activating the CCL3/CCL5-CCR1-MAPK-PD-L1 Pathway in Esophageal Squamous Cell Carcinoma.

Huiqin Yang, Jiahao Cai, Xiaolong Huang

|Jun 03, 2024
MNT inhibits lung adenocarcinoma ferroptosis and chemosensitivity by suppressing SAT1.

Guangyin Zhao, Jiaqi Liang, Yuchen Zhang

|May 29, 2023
KLF11 regulates lung adenocarcinoma ferroptosis and chemosensitivity by suppressing GPX4.

Guangyin Zhao, Jiaqi Liang, Guangyao Shan

Pageof 2

Frequent Collaborators

3 joint publications

Cheng Zhan

2 joint publications

Jie Gu

1 joint publications

Chunyi Zhang

1 joint publications

Jiahao Cai